ivd News

Increasingly, IT systems are part of the diagnostic market and sales of systems are a priority for DX companies.

A new report by London-based business information company visiongain predicts that world in vitro diagnostic revenues will reach $59.2bn in 2015. That market generated $44.6bn in 2010.

Transasia Bio-Medicals Ltd. and Erba Diagnostics Mannheim GmBH along with their other subsidiaries have a major presence at AACC Clinical Lab Expo 2011 being organised at Atlanta, Georgia, USA from July 26 – 28, 2011.

On 14th Jan 2011, Erba Diagnostics Mannheim, GmbH acquired a 100% stake in Diasis Diagnostik Sistemler Ticaret Ve Sanayi A.S. [Diasis Diagnostic Systems], a reputed company in the field of IVD, headquartered in Istanbul, Turkey.

Our new report examines the commercial prospects for in vitro diagnostics (IVD) in the global healthcare market.

In 2008 and 2009, IVD companies small and large engaged in acquisitions to expand their product menu and pipeline or to create a larger footprint. Several acquisition events are of particular interest.

Bharatbook added a new report on "Global In Vitro Diagnostics (IVD) Market Trends and Future Forecast (2009 - 2014)" examines the commercial prospects for In Vitro Diagnostics (IVD) in the global healthcare market.

IVD is a worldwide business. While the US is a large healthcare market, much of the dynamism occurs in other areas. Many of the most interesting developments are occurring in emerging markets.

Bharatbook added a new report on "South Africa In Vitro Diagnostics Market Outlook to 2016" provides key market data on the South Africa In Vitro Diagnostics (IVD) market.

TRANSASIA BIO-MEDICALS LTD., through its fully owned German subsidiary, Erba Diagnostics Mannheim GmbH has acquired a majority stake in US based company IVAX Diagnostics, Inc.

Bharatbook added a new report on "Global Molecular Diagnostics Market: Opportunities & Future Forecast" which gives the challenges and growth of Molecular Diagnostics Market.

IVD is a global business. While the U.S. is a large healthcare market, much of the dynamism occurs in other areas. Many of the most interesting developments are occurring in emerging markets, a reality that has aided the market despite economic woes.

Bharatbook added a new report on "IVD Market in BRIC Countries" which gives opportunities, key players, and competitive outlook of IVD Market in BRIC Countries.

Today, Global Research & Data Services is going to publish several market analyses about the In Vitro Diagnostic markets in the world.

Bharatbook added a new report on "Argentina In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015" which analyze the strengths and weaknesses of IVD industry in Argentina.

Bharatbook added a new report on "In vitro diagnostics market in Poland 2010" which gives epidemiologic and demographic trends of IVD market in Poland.

Bharatbook.com added a new report on "The Future of the In-Vitro Diagnostics Market to 2016 - Increasing Diagnostic Procedures Drive Demand" gives Qualitative analysis of key market trends, market drivers and restraints by categories and segments.

The global I-vitro diagnostics market is expected to show high growth to a value of $42.57 billion in 2012.

The global In Vitro Diagnostics (IVD) market, valued at $33.89 billion in 2008, has seen increased private equity/venture capital funding over the past two years.

Bharatbook.com added a new report on "In Vitro Diagnostics: Development Through Postmarket (PH101)" which gives IVD development investments and Marketing organization budgets.

Biosearch Technologies, Inc. has responded to the swine influenza pandemic, also known as 2009 H1N1, by offering the synthesis of all research use only oligonucleotide probes and primers composing the swine flu detection panel disclosed by the CDC.

Netscribes (India) Pvt. Ltd., launches a report on Medical Diagnostics covering testing centers and IVD suppliers. The report is part of Netscribes’ Healthcare Industry report series.